Christine R. Kincaid , MD

Associate Professor

Organization:

West Virginia University School of Medicine

Department:

Pediatrics

Classification:

Clinical Faculty

Associate Professor, General Internal Medicine

Organization:

West Virginia University School of Medicine

Department:

Medicine

Classification:

Clinical Faculty

• MD, WVU School of Medicine, 1985

1998    Kincaid C, Sherman D, Aronoff SC.  Endemic Pulmonary Mycoses.  Seminars in Pediatric Infectious Disease. 1998;9(2):84.

2000    Nuss, Kincaid.  Does Serotonin Discontinuation Syndrome Really Exist?  West Virginia Medical Journal March/April 2000

2000    Kincaid. Pediatric clinical case for MSI PBL class - Bacterial meningitis and its complications in a six month old child.

2006    Kincaid CR, Nield LS, Hsieh D, Friederich R, Pelszynski MM, Mule F, et al.  Index of Suspicion.  Pediatr Rev. 2006;27(8):307-313

2007    Kincaid CR, Nield LS, Moore RS, Keller FG, Post Transplant Lymphoproliferative Disease; A Case Report and Review for the General Pediatrician. Clinical  Pediatric  2007 May;46(4):287-91

2008     Davisson L, Warden M, Manivannan S, Kolar M, Kincaid C, Bashir S, Layne R,. Osteoporosis Screening: Factors Associated with Bone Mineral Density Testing of Older Women. Women’s Health 18(7):989.994, 2008.

2009     Davisson L, Warden M, Manivannan S, Kolar MM, Kincaid C, Bashir S, Layne R. Osteoporosis screening: factors associated with bone mineral density testing of  older women. Journal of Women’s Health. July 2009, 18(7):989-994.   

. 

Honors/Awards

2000    Clinician of the Year; voted by the graduating senior medical students class of 2000

1999 - 2000     Teaching Scholars Program

Selected as one of eight to participate in a multi-disciplinary faculty development program designed to promote excellence and scholarship in teaching.  Areas of study includes adult learning theory, critical thinking, exploring new technology available for teaching, developing communication skills to name a few. 

Dr. Christine Kincaid, MD, graduated from WVU School of Medicine in 1985 and went to complete her Internal Medicine/Pediatric residency at WVU in 1989. She worked for two years in student health, helping to care for the college population. During this period, she also worked in the General Pediatric outpatient clinic. She then accepted and shared appointment in the departments of General Internal Medicine and Pediatrics. During her career, Dr. Kincaid has served as an inpatient attending for both departments. In addition, she sees children and adults directly, and also precepts residents in both General Internal Medicine and Pediatric clinics. She served as the Program Director for General Internal Medicine and Pediatrics residency from 1997-2005. She remains an active participant in resident and medical student education, as well as being a primary care physician. 

2007 – 2010    Pfizer, “A 1-year , randomized, double-blind, placebo-controlled phase 3 study to evaluate the efficacy and safety of CP-945,598 in the treatment of overweight, oral agent-treated subjects with Type 2 Diabetes Mellitus.

2006 - 2010     Sanofi-aventis, “A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to assess the efficacy and safety of long-term administration of rimonabant in the prevention of type 2 diabetes in patients with prediabetic status (RAPSODI)” (P-Investigator)

2006 - 2010     Pfizer, “A 2-year, randomized, double-blind, placebo-controlled phase 3 study to evaluate the long-term efficacy and safety of CP-945,598 in the treatment of obsess subjects” (P-Investigator)

2005 - 2010     Sanof-Aventis, “A randomized, Double-Blind, Two-Arms Placebo-Controlled, Parallel-Group, Multicenter Study of Rimonabant 20 mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdominally Obese Patients” (Sub-Investigator)

2002     Co-investigator, “Prevalence of Colonization of Meth Resistant S Aueus and Pen Res Strep Pneumo in a Healthy Population of Children in WV”

2000     Sub-investigator, A prospective open-label non-randomized naturalistic long-term safety surveillance observational study of ciprofloxacin (either as oral suspension, oral tablets or sequential IV to oral therapy or parely IV therapy) in the treatment of pediatric patients with a variety of infectious diagnosis.

1995 - 1996     Co-investigator, Use of steroid in acute croup to prevent hospitalization

1993 - 1999     Co-investigator, Prostate Cancer Prevention Trial

1993     Seat Belt Use Among Rural Adults

Medical Specialties

• Internal Medicine
• Pediatrics

Board Certifications

• Internal Medicine, American Board of Internal Medicine
• Pediatrics, American Board of Pediatrics

Special Training

• Fellowship, Ambulatory Pediatrics and Internal Medicine
  West Virginia University, 1990
• Residency, Internal Medicine/Pediatrics
  West Virginia University, 1989